biostudies-literatureUnknown2(1)Wimmer MR<h4>Objective</h4>The coronavirus disease 2019 (COVID-19) pandemic has required healthcare systems and hospitals to rapidly modify standard practice, including antimicrobial stewardship services. Our study examines the impact of COVID-19 on the antimicrobial stewardship pharmacist.<h4>Design</h4>A survey was distributed nationally to all healthcare improvement company members.<h4>Participants</h4>Pharmacist participants were mostly leaders of antimicrobial stewardship programs distributed evenly across the United States and representing urban, suburban, and rural health-system practice sites.<h4>Results</h4>Participants reported relative increases in time spent completing tasks related to medication access and preauthorization (300%; <i>P</i> = .018) and administrative meeting time (34%; <i>P</i> = .067) during the COVID-19 pandemic compared to before the pandemic. Time spent rounding, making interventions, performing pharmacokinetic services, and medication reconciliation decreased.<h4>Conclusion</h4>A shift away from clinical activities may negatively affect the utilization of antimicrobials.Antimicrobial stewardship & healthcare epidemiology : ASHEe56https://www.ebi.ac.uk/biostudies/studies/S-EPMC9726570biostudies-literatureThe impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey.PMC9726570Schulz LTJain RPostelnick MSchwei RJBrett MHolubar MWalraven CLarry RWimmer MRFong KBurgess DRNjoku JPulia MSNewland HHamel AGHale CMSpivak ESfalseThe impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey.<h4>Objective</h4>The coronavirus disease 2019 (COVID-19) pandemic has required healthcare systems and hospitals to rapidly modify standard practice, including antimicrobial stewardship services. Our study examines the impact of COVID-19 on the antimicrobial stewardship pharmacist.<h4>Design</h4>A survey was distributed nationally to all healthcare improvement company members.<h4>Participants</h4>Pharmacist participants were mostly leaders of antimicrobial stewardship programs distributed evenly across the United States and representing urban, suburban, and rural health-system practice sites.<h4>Results</h4>Participants reported relative increases in time spent completing tasks related to medication access and preauthorization (300%; <i>P</i> = .018) and administrative meeting time (34%; <i>P</i> = .067) during the COVID-19 pandemic compared to before the pandemic. Time spent rounding, making interventions, performing pharmacokinetic services, and medication reconciliation decreased.<h4>Conclusion</h4>A shift away from clinical activities may negatively affect the utilization of antimicrobials.2022-01-01T00:00:00Z20222025-04-19T05:57:37.378Z2025-04-19T05:57:37.378ZS-EPMC97265703648336410.1017/ash.2022.37